Kewl is a commercial stage Chinese medtech developing a disruptive co-ablation technology (cryoablation and thermal ablation) for the treatment of solid tumor. The device is CE marked and China NMPA approved. The company has raised over $100million from top investors. Their technology used Liquid Nitrogen (vs Argon) for cooling which significantly reduces costs and increased access globally. Looking for distribution partners globally (ex-China). 

​Click here to receive more information about the Kewl, and reserve its roadshow next month.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s